Monitor supply of drugs under COVID Treatment Protocol including Remdesivir, Toclizomab: MHA to States, UTs Medical Dialogues Team23 April 2021 7:34 PM ISTNew Delhi: The Ministry of Home Affairs (MHA) has issued a notice to all Union Territories (UTs) and States urging them to monitor the supply of...
Mankind pharma in talks with Russia to market Sputnik V Covid-19 vaccine: Report Medical Dialogues Team22 April 2021 2:35 PM ISTNew Delhi: Delhi-based Mankind Pharma recently announced that it is in discussions with Russia to market the Sputnik V COVID-19 vaccine, reports Money...
Submit 28 days trial results of Hepatitis C drug for Covid-19: CDSCO panel to Zydus Cadila Medical Dialogues Team21 April 2021 11:12 AM ISTNew Delhi: In response to the drug major Zydus Cadila's proposal for marketing authorisation of the Hepatitis C drug, Pegylated Interferon Alpha-2b...
Publish efficacy, ensure availability of COVID drug Remdesivir through Govt hospitals: IPA writes to DCGI Medical Dialogues Team21 April 2021 11:00 AM ISTNew Delhi: Condemning the rampant black marketing of Remdesivir, the Indian Pharmacist Association (IPA) has recently written to the Union Health...
CDSCO Allows Import Of Drugs With Residual Shelf Life Less Than 60 Percent Till October 31, 2021 Medical Dialogues Team20 April 2021 12:06 PM ISTNew Delhi: To ensure drug availability in sufficient quantity in the domestic market, the apex drug regulator, Central Drugs Standard Control...
Jubilant Pharma develops novel oral formulation of Remdesivir, seeks DCGI nod for additional studies Medical Dialogues Team20 April 2021 11:43 AM ISTNew Delhi: Jubilant Pharma Limited, a subsidiary of Jubilant Pharmova Limited, has recently announced that it has successfully completed safety and...
Union Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccines Ruchika Sharma16 April 2021 4:44 PM ISTNew Delhi: The Central government on Thursday issued the regulatory pathway in India for Covid-19 vaccines approved for restricted use by US FDA, EMA,...
DCGI authorizes Sputnik V for emergency use in India Ruchika Sharma13 April 2021 11:30 AM ISTNew Delhi: India''s drug regulator has granted permission for the restricted emergency use of Russian COVID-19 vaccine '"Sputnik V" with certain...
In line with DCGI notice, AIOCD asks chemist members to avoid overcharging, hoarding of Remdesivir Medical Dialogues Team10 April 2021 4:03 PM ISTNew Delhi: In line with a notice by the Drugs Controller General of India (DCGI) regarding the supply of Covid-19 drug Remdesivir without hoarding or...
Setback to Serum Institute: WHO rejects proposal to extend Covishield shelf life Ruchika Sharma9 April 2021 1:50 PM ISTNew Delhi: In a major setback to Serum Institute of India (SII), the World Health Organization (WHO) has rejected the vaccine maker's proposal...
COVID-19: Zydus Cadila seeks DCGI nod for Pegylated Interferon alpha-2b Medical Dialogues Bureau5 April 2021 11:24 AM ISTAhmedabad: Drugmaker, Zydus Cadila, announced that its Phase III clinical trials with Pegylated Interferon Alpha 2b, PegiHep has shown promising...
Clinical Trial for third dose of Covaxin gets DCGI panel okay Ruchika Sharma3 April 2021 12:00 PM ISTNew Delhi: The expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give a third dose of Covaxin to a few volunteers in its...
